title: Notes from the field: Shigella with decreased susceptibility to azithromycin among men who have sex with men - United States, 2002-2013.
abstract: Bacteria of the genus Shigella cause approximately 500,000 illnesses each year in the United States. Diarrhea (sometimes bloody), fever, and stomach cramps typically start 1-2 days after exposure and usually resolve in 5-7 days. For patients with severe disease, bloody diarrhea, or compromised immune systems, antibiotic treatment is recommended, but resistance to traditional first-line antibiotics (e.g., ampicillin and trimethoprim-sulfamethoxazole) is common. For multidrugresistant cases, azithromycin, the most frequently prescribed antibiotic in the United States, is recommended for both children and adults. However, not all Shigellae are susceptible to azithromycin. Nonsusceptible isolates exist but are not usually identified because there are no clinical laboratory guidelines for azithromycin susceptibility testing. However, to monitor susceptibility of Shigellae in the United States, CDC's National Antimicrobial Resistance Monitoring System (NARMS) has, since 2011, routinely measured the azithromycin minimum inhibitory concentration (MIC) for every 20th Shigella isolate submitted from public health laboratories to CDC, as well as outbreak-associated isolates. All known U.S. Shigella isolates with decreased susceptibility to azithromycin (DSA-Shigella), and the illnesses caused by them, are described in this report.
authors: Katherine E
authors: KE
authors: Heiman
authors: Maria
authors: M
authors: Karlsson
authors: Julian
authors: J
authors: Grass
authors: Becca
authors: B
authors: Howie
authors: Robert D
authors: RD
authors: Kirkcaldy
authors: Barbara
authors: B
authors: Mahon
authors: John T
authors: JT
authors: Brooks
authors: Anna
authors: A
authors: Bowen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D017963:Azithromycin / Q000494:pharmacology* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D024881:Drug Resistance, Bacterial; D004405:Dysentery, Bacillary / Q000188:drug therapy*; D005260:Female; D018451:Homosexuality, Male; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D012760:Shigella / Q000187:drug effects* / Q000302:isolation & purification; D014481:United States; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D017963:Azithromycin